- Home
- SUI vs AXSM Comparison
SUI vs AXSM Comparison
Compare SUI & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SUI | AXSM |
|---|---|---|
| Founded | 1975 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 12.0B |
| IPO Year | 1996 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SUI | AXSM |
|---|---|---|
| Price | $123.28 | $244.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 17 |
| Target Price | $141.21 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 1.2M | 848.9K |
| Earning Date | 04-27-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | ★ 1426.76 | 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,306,100,000.00 | N/A |
| Revenue This Year | $5.24 | $57.24 |
| Revenue Next Year | $5.08 | $55.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $115.53 | $96.09 |
| 52 Week High | $137.85 | $260.19 |
Technical Indicators
Market Signals| Indicator | SUI | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 56.60 |
| Support Level | $119.24 | $236.44 |
| Resistance Level | $128.99 | $260.19 |
| Average True Range (ATR) | 2.82 | 8.34 |
| MACD | 0.21 | -1.78 |
| Stochastic Oscillator | 60.91 | 33.14 |
Price Performance
Historical ComparisonAbout SUI Sun Communities Inc.
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 513 properties, which includes 347 manufactured housing communities and 166 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties, with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.